Coronary interventions

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

EuroIntervention 2015;11:149-156 published online ahead of print December 2014. DOI: 10.4244/EIJY14M12_10

Jochen Wöhrle1, MD; Christoph Naber2, MD; Thomas Schmitz2, MD; Carsten Schwencke3, MD; Norbert Frey4, MD; Christian Butter5, MD; Johannes Brachmann6, MD; Maja Ingwersen3, DVM; Anna Drabik7, PhD; Sinisa Markovic1, MD; Detlef G. Mathey3*, MD

1. Department of Internal Medicine II, University of Ulm, Ulm, Germany; 2. Department of Cardiology and Angiology, Elisabeth-Krankenhaus Essen, Essen, Germany; 3. University Cardiovascular Center Hamburg, Hamburg, Germany; 4. Department of Cardiology and

Aims: Bioresorbable vascular scaffolds (BVS) have been available on the European market since November 2011. The ASSURE registry aims to investigate the safety and efficacy of the Absorb

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bioresorbable vascular scaffoldcoronary artery diseasepercutaneous coronary intervention

Share on Facebook Share on Twitter Share on Linkedin

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

Latest news